Weight change in treatment with olanzapine and a psychoeducational approach

Eating Behaviors

Volumn 7, Issue 2, 2006, Pages 115-124

  Scocco, Paolo ^a   Longo, Raffaella ^b   Caon, Federico ^c  

^a ULSS 16   (Italy)

^b Mental Health Department   (Italy)

^c NONE

Author keywords

Olanzapine; Psychoeducational approach; Schizophrenia; Weight change; Weight control

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE;

ADULT; AGED; AKATHISIA; ANALYSIS OF VARIANCE; ARTICLE; BODY WEIGHT DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIETARY INTAKE; DOSE RESPONSE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MALE; NUTRITIONAL COUNSELING; PARKINSONISM; PATIENT COMPLIANCE; PATIENT REFERRAL; PRIORITY JOURNAL; PSYCHOEDUCATION; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; TARDIVE DYSKINESIA; WEIGHT GAIN; WEIGHT REDUCTION;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BODY WEIGHT; FEMALE; HEALTH EDUCATION; HUMANS; MALE; MIDDLE AGED; OBESITY; PATIENT EDUCATION; PREVALENCE; SCHIZOPHRENIA;

EID: 33645877106     PISSN: 14710153     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eatbeh.2005.08.003     Document Type: Article

References (19)

1. Allison D.B., and Casey D.E. Antipsychotic-induced weight gain: A review of the literature. Journal of Clinical Psychiatry 62 suppl 7 (2001) 22-31
2. Allison D.B., Fontaine K.R., Heo M., Mentore J.L., Cappelleri J.C., Chandler L.P., et al. The distribution of body mass index among individuals with and without schizophrenia. Journal of Clinical Psychiatry 60 (1999) 215-220
3. Allison D.B., Mentore J.L., Heo M., Chandler L.P., Cappelleri J.C., Infante M.C., et al. Antipsychotic-induced weight gain: A comprehensive research synthesis. American Journal of Psychiatry 156 (1999) 1686-1696
4. Ball M.P., Coons V.B., and Buchanan R.W. A program for treating Olanzapine-related weight gain. Psychiatry Service 52 (2001) 967-969
5. Basson B.R., Kinon B.J., Taylor C.C., Szymansk K.A., Gilmore J.A., and Tollefson G.D. Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. Journal of Clinical Psychiatry 62 (2001) 231-238
6. Bazire, S. (2000). Psychotropic drug directory. Quay Books, Mark Allen Publishing Ltd, Jesses Farm; Snow Hill, Dinton, Nr Salisbury, Wilts.
7. Beasley Jr. C.M., Sanger T., Satterlee W., Tollefson G., Tran P., and Hamilton S. Olanzapine versus placebo: Results of a double-blind, fixed-dose olanzapine trial. Psychopharmacology 124 (1996) 159-167
8. Blin O., and Micallef J. Antipsychotic-associated weight gain and clinical outcome parameters. Journal of Clinical Psychiatry 62 suppl. 7 (2001) 11-21
9. Eder U., Mangweth B., Ebenbichler C., Weiss E., Hofer A., Hummer M., et al. Association of olanzapine-induced weight gain with an increase in body fat. American Journal of Psychiatry 158 (2001) 1719-1722
10. Kalucy R.S. Drug induced weight gain. Drugs 19 (1980) 268-278
11. Kinon B.J., Basson B.R., Gilmore J.A., and Tollefson G.D. Long-term olanzapine treatment: Weight change and weight-related health factors in schizophrenia. Journal of Clinical Psychiatry 62 (2001) 92-100
12. Kurzthaler I., and Fleischhacker W. The clinical implications of weight gain in schizophrenia. Journal of Clinical Psychiatry 62 suppl 7 (2001) 32-37
13. Osser D.N., Najarian D.M., and Dufresne R.L. Olanzapine increases weight and serum triglyceride levels. Journal of Clinical Psychiatry 60 (1999) 767-770
14. Rotatori A.F., Fox R., and Wilcks A. Weight loss with psychiatric residents in a behavioral self control program. Psychological Report 46 (1980) 483-486
15. Tollefson G.D., Beasley C.M., Tran P.V., Street J.S., Krueger J.A., Tamura R.N., et al. Olanzapine versus Haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an international collaborative trial. American Journal of Psychiatry 154 (1997) 458-465
16. Tran P.V., Hamilton S.H., Kuntz A.J., Potvin J.H., Andersen S.W., Beasley Jr. C., et al. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. Journal Clinical Psychopharmacology 17 (1997) 407-418
17. Venables-Ripley. Modern applied statistics with S-Plus (1994), Wiley, NY
18. Windgassen K., Wesselmann U., and Schulze Monking H. Galactorrhea and hyperprolactinemia in schizophrenic patients on neuroleptics: Frequency and etiology. Neuropsychobiology 33 (1996) 142-146
19. Wirshing D.A., Wirshing W.C., Kysar L., Berisford M.A., Goldstein D., Pashdag J., et al. Novel antipsychotics: Comparison of weight gain liabilities. Journal of Clinical Psychiatry 60 (1999) 358-363